Research ArticleANTIVIRAL IMMUNITY

PGD2/DP2 receptor activation promotes severe viral bronchiolitis by suppressing IFN-λ production

See allHide authors and affiliations

Science Translational Medicine  09 May 2018:
Vol. 10, Issue 440, eaao0052
DOI: 10.1126/scitranslmed.aao0052

Article Information

vol. 10 no. 440

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication June 5, 2017
  • Resubmitted November 17, 2017
  • Accepted for publication March 12, 2018

Author Information

  1. Rhiannon B. Werder1,
  2. Jason P. Lynch1,
  3. Jennifer C. Simpson1,2,
  4. Vivian Zhang2,
  5. Nick H. Hodge1,
  6. Matthew Poh3,
  7. Elizabeth Forbes-Blom4,
  8. Christina Kulis5,
  9. Mark L. Smythe5,
  10. John W. Upham6,
  11. Kirsten Spann7,8,
  12. Mark L. Everard3 and
  13. Simon Phipps2,7,*
  1. 1School of Biomedical Sciences, University of Queensland, Queensland 4072, Australia.
  2. 2Queensland Institute of Medical Research Berghofer Medical Research Institute, Herston 4006, Australia.
  3. 3School of Paediatrics and Child Health, University of Western Australia, Western Australia 6840, Australia.
  4. 4Malaghan Institute of Medical Research, Wellington 6242, New Zealand.
  5. 5Institute for Molecular Bioscience, University of Queensland, Queensland 4072, Australia.
  6. 6Diamantina Institute, University of Queensland, Translational Research Institute, Princess Alexandra Hospital, Queensland 4102, Australia.
  7. 7Australian Infectious Diseases Research Centre, University of Queensland, Queensland 4067, Australia.
  8. 8School of Biomedical Sciences, Queensland University of Technology, Queensland 4001, Australia.
  1. *Corresponding author. Email: simon.phipps{at}qimrberghofer.edu.au

Altmetric

Article usage

Article usage: May 2018 to October 2018

AbstractFullPdf
May 20184877146315
Jun 20184132458
Jul 20181993033
Aug 20181134040
Sep 20181032523
Oct 201863179